Study: Misuse Of Patent System Affecting Health System In Australia 10/04/2013 by Intellectual Property Watch Leave a Comment Research from the University of Melbourne has found that patents may be keeping pharmaceuticals expensive in Australia, but said that most of the patents are being taken out by companies that are not the originators of the drugs.
Linguistic Diversity Essential For Innovation, Development, Roundtable Speakers Say 04/04/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment Multilingualism not only expands cultural horizons but also provides a tool for innovation, speakers gathered at an international roundtable yesterday said. However, language uniformity is a tempting road taken by many – often for cost-related reasons – while multilingualism should be promoted as a factor in development, they said.
Australian Pharmaceutical Patents Review Draft Report Critical Of Patent Extensions, R&D Funding 03/04/2013 by Kelly Burke for Intellectual Property Watch Leave a Comment The Australian Pharmaceutical Patents Review yesterday issued its draft report, recommending that the Australian government reduce pharmaceutical patent extension terms and use estimated savings to subsidise research and development.
Pharma, International Red Cross Combine To Fight NCDs 19/03/2013 by Intellectual Property Watch Leave a Comment The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced on 19 March a two-year partnership on non-communicable diseases.
Tuberculosis: WHO, Global Fund Call For Mobilisation Of Funds As Resistance Rises 18/03/2013 by Catherine Saez, Intellectual Property Watch 2 Comments Tuberculosis is now a renewed threat, with strains that prove resistant to multiple drugs and are transmissible and the potential to spread widely, according to the World Health Organization and the Global Fund, which are looking for US$1.6 billion a year to prevent the spread of the disease.
Patent Pool-ViiV Collaboration On Paediatric HIV Sparks Reactions, Hope 04/03/2013 by William New, Intellectual Property Watch 1 Comment The Medicines Patent Pool has announced a ground-breaking collaboration with a private sector joint venture that it said will facilitate greater availability of critical medicines for children with HIV worldwide. The announcement caused a wave of positive reactions across the public health community, with many hoping for more in the future.
Global Health Giants, Trade Deals, And IP Play Central Role In 2013 Public Health Policy 28/02/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment The role of intellectual property in a wide range of public health challenges – access to medicines, vaccine prices, procurement strategies, and research for diseases of the poor – is a focal point in 2013 cutting across national, regional, and international policymaking.
WIPO Members Struggle To Define Work Programme On Patents And Health 27/02/2013 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment As the World Intellectual Property Organization’s patent law committee grapples with starkly differing positions on the topic of patents and health, the secretariats of WIPO, the World Health Organization and World Trade Organization presented to members how their first trilateral study on access to medical technologies and innovation could be used as an effective resource. While the secretariats emphasised the neutral, informative nature of the book, some members pointed to a need for greater analysis of the challenges developing countries face when trying to use patent flexibilities for access to medicines.
UN Takes On Organised Crime And Fraudulent Medicines 15/02/2013 by William New and Tiphaine Nunzia Caulier for Intellectual Property Watch 2 Comments The United Nations has become a focal point for global efforts to fight organised crime’s trafficking of fraudulent medicines that put millions of people – especially the poor – at risk. And a recent pharmaceutical industry report on such medicines recommended some solutions.
Report Proposes Solutions To Address Non-Communicable Diseases 11/02/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch 1 Comment An industry-backed group of experts has issued a report identifying significant obstacles to addressing non-communicable diseases (NCDs) and proposing solutions to reduce premature deaths caused by NCDs.